Genome-Wide Identification of Fas/CD95 Alternative Splicing Regulators Reveals Links with Iron Homeostasis

Molecular Cell

Volumn 57, Issue 1, 2015, Pages 23-38

  Tejedor, J Ramón ^a,b   Papasaikas, Panagiotis ^a,b   Valcárcel, Juan ^a,b,c  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IRON; SMALL INTERFERING RNA; SRSF7 PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DEFEROXAMINE; DIABLO PROTEIN, HUMAN; IRON CHELATING AGENT; ISOPROTEIN; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; PROTEIN BINDING; RNA BINDING PROTEIN; SERINE-ARGININE-RICH SPLICING PROTEINS; SIGNAL PEPTIDE;

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE IDENTIFICATION; HOMEOSTASIS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MAMMAL CELL; METABOLIC REGULATION; RNA BINDING; RNA PROCESSING; RNA TRANSPORT; SPLICEOSOME; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BINDING SITE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETICS; GENOME; HELA CELL LINE; INTRON; METABOLISM; MOLECULAR GENETICS;

MAMMALIA;

ALTERNATIVE SPLICING; ANTIGENS, CD95; APOPTOSIS; BINDING SITES; CELL PROLIFERATION; DEFEROXAMINE; EXONS; GENE REGULATORY NETWORKS; GENOME; GENOME-WIDE ASSOCIATION STUDY; HELA CELLS; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRONS; IRON; IRON CHELATING AGENTS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE ANNOTATION; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SPLICEOSOMES;

EID: 84920376732     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.10.029     Document Type: Article

References (69)

1. Acevedo V.D., Ittmann M., Spencer D.M. Paths of FGFR-driven tumorigenesis. Cell Cycle 2009, 8:580-588.
2. Albulescu L.O., Sabet N., Gudipati M., Stepankiw N., Bergman Z.J., Huffaker T.C., Pleiss J.A. A quantitative, high-throughput reverse genetic screen reveals novel connections between Pre-mRNA splicing and 5' and 3' end transcript determinants. PLoS Genet. 2012, 8:e1002530.
3. Barbosa-Morais N.L., Irimia M., Pan Q., Xiong H.Y., Gueroussov S., Lee L.J., Slobodeniuc V., Kutter C., Watt S., Colak R., et al. The evolutionary landscape of alternative splicing in vertebrate species. Science 2012, 338:1587-1593.
4. Batsché E., Yaniv M., Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 2006, 13:22-29.
5. Blaustein M., Pelisch F., Tanos T., Muñoz M.J., Wengier D., Quadrana L., Sanford J.R., Muschietti J.P., Kornblihtt A.R., Cáceres J.F., et al. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 2005, 12:1037-1044.
6. Braunschweig U., Gueroussov S., Plocik A.M., Graveley B.R., Blencowe B.J. Dynamic integration of splicing within gene regulatory pathways. Cell 2013, 152:1252-1269.
7. Campillos M., Cases I., Hentze M.W., Sanchez M. SIREs: searching for iron-responsive elements. Nucleic Acids Res. 2010, 38:W360-W367.
8. Cascino I., Fiucci G., Papoff G., Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J.Immunol. 1995, 15:2706-2713.
9. Cavaloc Y., Bourgeois C.F., Kister L., Stévenin J. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 1999, 5:468-483.
10. Chen L., Xiao S., Manley N.R. Foxn1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner. Blood 2009, 113:567-574.
11. Chen L., Park S.M., Tumanov A.V., Hau A., Sawada K., Feig C., Turner J.R., Fu Y.X., Romero I.L., Lengyel E., Peter M.E. CD95 promotes tumour growth. Nature 2010, 465:492-496.
12. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994, 263:1759-1762.
13. Chew S.K., Chen P., Link N., Galindo K.A., Pogue K., Abrams J.M. Genome-wide silencing in Drosophila captures conserved apoptotic effectors. Nature 2009, 460:123-127.
14. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., Fleming M.D., Schreiber S.L., Cantley L.C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
15. Clark T.A., Sugnet C.W., Ares M. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science 2002, 296:907-910.
16. Cléry A., Sinha R., Anczuków O., Corrionero A., Moursy A., Daubner G.M., Valcárcel J., Krainer A.R., Allain F.H. Isolated pseudo-RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognition. Proc. Natl. Acad. Sci. USA 2013, 110:E2802-E2811.
17. Conte D., Narindrasorasak S., Sarkar B. Invivo and invitro iron-replaced zinc finger generates free radicals and causes DNA damage. J.Biol. Chem. 1996, 271:5125-5130.
18. David C.J., Chen M., Assanah M., Canoll P., Manley J.L. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463:364-368.
19. de Almeida S.F., Grosso A.R., Koch F., Fenouil R., Carvalho S., Andrade J., Levezinho H., Gut M., Eick D., Gut I., et al. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat. Struct. Mol. Biol. 2011, 18:977-983.
20. de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M.A., Pelisch F., Cramer P., Bentley D., Kornblihtt A.R. A slow RNA polymerase II affects alternative splicing invivo. Mol. Cell 2003, 12:525-532.
21. diTargiani R.C., Lee S.J., Wassink S., Michel S.L. Functional characterization of iron-substituted tristetraprolin-2D (TTP-2D, NUP475-2D): RNA binding affinity and selectivity. Biochemistry 2006, 45:13641-13649.
22. Dujardin G., Lafaille C., Petrillo E., Buggiano V., Gómez Acuña L.I., Fiszbein A., Godoy Herz M.A., Nieto Moreno N., Muñoz M.J., Alló M., et al. Transcriptional elongation and alternative splicing. Biochim. Biophys. Acta 2013, 1829:134-140.
23. Fica S.M., Tuttle N., Novak T., Li N.S., Lu J., Koodathingal P., Dai Q., Staley J.P., Piccirilli J.A. RNA catalyses nuclear pre-mRNA splicing. Nature 2013, 503:229-234.
24. Fu X.D., Ares M. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 2014, 15:689-701.
25. Gazin C., Wajapeyee N., Gobeil S., Virbasius C.M., Green M.R. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007, 449:1073-1077.
26. Gray N.K., Hentze M.W. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J. 1994, 13:3882-3891.
27. Hamady M., Walker J.J., Harris J.K., Gold N.J., Knight R. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat. Methods 2008, 5:235-237.
28. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell 2010, 142:24-38.
29. Hoskins A.A., Moore M.J. The spliceosome: a flexible, reversible macromolecular machine. Trends Biochem. Sci. 2012, 37:179-188.
30. Huang Y., Steitz J.A. Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol. Cell 2001, 7:899-905.
31. Huang Y., Yario T.A., Steitz J.A. A molecular link between SR protein dephosphorylation and mRNA export. Proc. Natl. Acad. Sci. USA 2004, 101:9666-9670.
32. Huff J.T., Plocik A.M., Guthrie C., Yamamoto K.R. Reciprocal intronic and exonic histone modification regions in humans. Nat. Struct. Mol. Biol. 2010, 17:1495-1499.
33. Ip J.Y., Schmidt D., Pan Q., Ramani A.K., Fraser A.G., Odom D.T., Blencowe B.J. Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Res. 2011, 21:390-401.
34. Izquierdo J.M., Majós N., Bonnal S., Martínez C., Castelo R., Guigó R., Bilbao D., Valcárcel J. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell 2005, 19:475-484.
35. Katz Y., Wang E.T., Airoldi E.M., Burge C.B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 2010, 7:1009-1015.
36. Kim S., Kim H., Fong N., Erickson B., Bentley D.L. Pre-mRNA splicing is a determinant of histone H3K36 methylation. Proc. Natl. Acad. Sci. USA 2011, 108:13564-13569.
37. Konig J., Zarnack K., Rot G., Curk T., Kayikci M., Zupan B., Turner D.J., Luscombe N.M., Ule J. iCLIP-transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. J. Vis. Exp. 2011, 30. 10.3791/2638.
38. Kornblihtt A.R., Schor I.E., Alló M., Dujardin G., Petrillo E., Muñoz M.J. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol. 2013, 14:6072-6083.
39. Krammer P.H. CD95's deadly mission in the immune system. Nature 2000, 407:789-795.
40. Li Y., Lin L., Li Z., Ye X., Xiong K., Aryal B., Xu Z., Paroo Z., Liu Q., He C., Jin P. Iron homeostasis regulates the activity of the microRNA pathway through poly(C)-binding protein 2. Cell Metab. 2012, 15:895-904.
41. Liu C., Cheng J., Mountz J.D. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J. 1995, 310:957-963.
42. Luco R.F., Allo M., Schor I.E., Kornblihtt A.R., Misteli T. Epigenetics in alternative pre-mRNA splicing. Cell 2011, 144:16-26.
43. Mackereth C.D., Madl T., Bonnal S., Simon B., Zanier K., Gasch A., Rybin V., Valcárcel J., Sattler M. Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF. Nature 2011, 475:408-411.
44. Merkin J., Russell C., Chen P., Burge C.B. Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. Science 2012, 338:1593-1599.
45. Moehle E.A., Ryan C.J., Krogan N.J., Kress T.L., Guthrie C. The yeast SR-like protein Npl3 links chromatin modification to mRNA processing. PLoS Genet. 2012, 8:e1003101.
46. Moore M.J., Wang Q., Kennedy C.J., Silver P.A. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010, 142:625-636.
47. Muckenthaler M., Richter A., Gunkel N., Riedel D., Polycarpou-Schwarz M., Hentze S., Falkenhahn M., Stremmel W., Ansorge W., Hentze M.W. Relationships and distinctions in iron-regulatory networks responding to interrelated signals. Blood 2003, 101:3690-3698.
48. Neumann B., Walter T., Hériché J.K., Bulkescher J., Erfle H., Conrad C., Rogers P., Poser I., Held M., Liebel U., et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010, 464:721-727.
49. Nilsen T.W., Graveley B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010, 463:457-463.
50. Papasaikas P., Ramón Tejedor J., Vigevani L., Valcárcel J. Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. Mol. Cell 2015, 57:7-22. this issue.
51. Papoff G., Cascino I., Eramo A., Starace G., Lynch D.H., Ruberti G. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death invitro. J.Immunol. 1996, 156:4622-4630.
52. Park J.W., Parisky K., Celotto A.M., Reenan R.A., Graveley B.R. Identification of alternative splicing regulators by RNA interference in Drosophila. Proc. Natl. Acad. Sci. USA 2004, 101:15974-15979.
53. Paz I., Akerman M., Dror I., Kosti I., Mandel-Gutfreund Y. SFmap: a web server for motif analysis and prediction of splicing factor binding sites. Nucleic Acids Res. 2010, 38:W281-W285.
54. Pleiss J.A., Whitworth G.B., Bergkessel M., Guthrie C. Transcript specificity in yeast pre-mRNA splicing revealed by mutations in core spliceosomal components. PLoS Biol. 2007, 5:e90.
55. Porto G., De Sousa M. Iron overload and immunity. World J. Gastroenterol. 2007, 13:4707-4715.
56. Ramm G.A., Ruddell R.G. Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: the role of inflammation in a noninflammatory liver disease. Semin. Liver Dis. 2010, 30:271-287.
57. Rausin G., Tillemans V., Stankovic N., Hanikenne M., Motte P. Dynamic nucleocytoplasmic shuttling of an Arabidopsis SR splicing factor: role of the RNA-binding domains. Plant Physiol. 2010, 153:273-284.
58. Ray D., Kazan H., Cook K.B., Weirauch M.T., Najafabadi H.S., Li X., Gueroussov S., Albu M., Zheng H., Yang A., et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 2013, 499:172-177.
59. Roesler J., Izquierdo J.M., Ryser M., Rösen-Wolff A., Gahr M., Valcarcel J., Lenardo M.J., Zheng L. Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95DeltaTM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele. Blood 2005, 106:1652-1659.
60. Saltzman A.L., Pan Q., Blencowe B.J. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev. 2011, 25:373-384.
61. Sanchez M., Galy B., Schwanhaeusser B., Blake J., Bähr-Ivacevic T., Benes V., Selbach M., Muckenthaler M.U., Hentze M.W. Iron regulatory protein-1 and -2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins. Blood 2011, 118:e168-e179.
62. Solier S., Lansiaux A., Logette E., Wu J., Soret J., Tazi J., Bailly C., Desoche L., Solary E., Corcos L. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. Mol. Cancer Res. 2004, 2:53-61.
63. Solier S., Barb J., Zeeberg B.R., Varma S., Ryan M.C., Kohn K.W., Weinstein J.N., Munson P.J., Pommier Y. Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors. Cancer Res. 2010, 70:8055-8065.
64. Soret J., Gabut M., Dupon C., Kohlhagen G., Stévenin J., Pommier Y., Tazi J. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I. Cancer Res. 2003, 63:8203-8211.
65. Strässer K., Masuda S., Mason P., Pfannstiel J., Oppizzi M., Rodriguez-Navarro S., Rondón A.G., Aguilera A., Struhl K., Reed R., Hurt E. TREX is a conserved complex coupling transcription with messenger RNA export. Nature 2002, 417:304-308.
66. Wahl M.C., Will C.L., Lührmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009, 136:701-718.
67. Warzecha C.C., Sato T.K., Nabet B., Hogenesch J.B., Carstens R.P. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol. Cell 2009, 33:591-601.
68. Zheng S., Damoiseaux R., Chen L., Black D.L. A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing. Genome Res. 2013, 23:998-1007.
69. Zhou Z., Qiu J., Liu W., Zhou Y., Plocinik R.M., Li H., Hu Q., Ghosh G., Adams J.A., Rosenfeld M.G., Fu X.D. The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol. Cell 2012, 47:422-433.